New to the Huntington's Disease Lighthouse?
 Welcome to the HDlighthouse!
 Getting started.
 
Home \ Research \ General \ Updates
The Huntingtin's protein plays a role in calcium signalling

HD Lighthouse Contributing Editor's Comment: 

The normal functions of the huntingtin's protein are still not fully understood. Although there are drugs and supplements now in clinical trials, basic research still needs to be done to answer key questions that will help in the development of efficient, effective treatments.

 

-- Marsha L. Miller, Ph.D.
Posted to the HDL: 05-27-2008

Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts.

Hua Zhang, Sudipto Das, Quan-Zhen Li, Ioannis Dragatsis, Joyce Repa, Scott Zeitlin, György Hajnóczky, and Ilya Bezprozvanny

Background:

The polyglutamine expansion in huntingtin (Htt) protein is a cause of Huntington's disease (HD). Htt is an essential gene as deletion of the mouse Htt gene homolog (Hdh) is embryonic lethal in mice. Therefore, in addition to elucidating the mechanisms responsible for polyQ-mediated pathology, it is also important to understand the normal function of Htt protein for both basic biology and for HD.

Results:

To systematically search for a mouse Htt function, we took advantage of the Hdh +/- and Hdh-floxed mice and generated four mouse embryonic fibroblast (MEF) cells lines which contain a single copy of the Hdh gene (Hdh-HET) and four MEF lines in which the Hdh gene was deleted (Hdh-KO). The function of Htt in calcium (Ca2+) signaling was analyzed in Ca2+ imaging experiments with generated cell lines. We found that the cytoplasmic Ca2+ spikes resulting from the activation of inositol 1,4,5-trisphosphate receptor (InsP3R) and the ensuing mitochondrial Ca2+ signals were suppressed in the Hdh-KO cells when compared to Hdh-HET cells. Furthermore, in experiments with permeabilized cells we found that the InsP3-sensitivity of Ca2+ mobilization from endoplasmic reticulum was reduced in Hdh-KO cells. These results indicated that Htt plays an important role in modulating InsP3R-mediated Ca2+ signaling. To further evaluate function of Htt, we performed genome-wide transcription profiling of generated Hdh-HET and Hdh-KO cells by microarray. Our results revealed that 106 unique transcripts were downregulated by more than two-fold with p < 0.05 and 173 unique transcripts were upregulated at least two-fold with p < 0.05 in Hdh-KO cells when compared to Hdh-HET cells. The microarray results were confirmed by quantitative real-time PCR for a number of affected transcripts. Several signaling pathways affected by Hdh gene deletion were identified from annotation of the microarray results.

Conclusion:

Functional analysis of generated Htt-null MEF cells revealed that Htt plays a direct role in Ca2+ signaling by modulating InsP3R sensitivity to InsP3. The genome-wide transcriptional profiling of Htt-null cells yielded novel and unique information about the normal function of Htt in cells, which may contribute to our understanding and treatment of HD.

# # #

Source: BMC Neuroscience 2008 Apr 15;9:38.

print this
printer friendly
version

 

Read the HDLighthouse Forum. Post your comments
   
Related Topics
Research focusing on the formation of aggregates caused by HD
 
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
 
Research related HD and it's general affect on the brain
 
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
 
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
 
Research focusing on gene therapy.
 
Research focusing on gene transcription.
 
Research studying the genetics of Huntington's Disease
 
Research studying the Immune System and it's effect on the progression of HD
 
Research studying the brain tissue and research related to stem cells
 

Recent Updates
25 Jul 2010
Sirtuin Inhibition Achieves Neuroprotection by Decreasing Sterol Biosynthesis
SIRT2 inhibition emerges as a promising therapeutic strategy.
 
24 May 2010
Cargo Recognition is Impaired in HD
Autophagy increases but is impaired, leading to an increase of the HD protein in the cytosol.
 
22 Dec 2009
Invitation to participate in a quality of life survey
Here is an opportunity to tell the medical professionals about quality of life issues.
 
6 Dec 2009
An interview with Dr. Jan Nolta
A trial of mesenchymal stem cell is planned for the end of 2010.
 
5 Dec 2009
Mesenchymal stem cells repair neurotoxin damage in an animal model
Preclinical work supports the use of mesenchymal stem cells to treat neurodegenerative disorders.
 
5 Dec 2009
The search for genetic modifiers
The search for genetic modifiers is an important part of the effort to find treatments.
 
20 Sep 2009
Axonal transport impaired in HD
Researchers have identified the mechanism by which axonal transport is impaired in neurons in HD.
 
4 Jul 2009
Rhes and the HD protein
Researchers at Johns Hopkins have discovered that a protein called rhes binds to the HD protein and causes toxicity.
 
24 Apr 2009
Acetylation of the HD protein
MSG-MIND researchers discover a new therapeutic target: increased acetylation enhances clearance of the HD ptotein from the nucleus.
 
31 Jan 2009
Impaired ERAD and ER stress
Cell model study shows that impaired ERAD and ER stress are early and specific events in polyglutamine toxicity.
 

All Updates for General
Disclaimer & Privacy Policy | Welcome | Site Feedback Marsha@HDLighthouse.org